Dopamine and glucose, obesity, and reward deficiency syndrome

Obesity as a result of overeating as well as a number of well described eating disorders has been accurately considered to be a world-wide epidemic. Recently a number of theories backed by a plethora of scientifically sound neurochemical and genetic studies provide strong evidence that food addiction is similar to psychoactive drug addiction. Our laboratory has published on the concept known as Reward Deficiency Syndrome (RDS) which is a genetic and epigenetic phenomena leading to impairment of the brain reward circuitry resulting in a hypo-dopaminergic function. RDS involves the interactions of powerful neurotransmitters and results in abnormal craving behavior. A number of important facts which could help translate to potential therapeutic targets espoused in this focused review include: (1) consumption of alcohol in large quantities or carbohydrates binging stimulates the brain’s production of and utilization of dopamine; (2) in the meso-limbic system the enkephalinergic neurons are in close proximity, to glucose receptors; (3) highly concentrated glucose activates the calcium channel to stimulate dopamine release from P12 cells; (4) a significant correlation between blood glucose and cerebrospinal fluid concentrations of homovanillic acid the dopamine metabolite; (5) 2-deoxyglucose (2DG), the glucose analog, in pharmacological doses is associated with enhanced dopamine turnover and causes acute glucoprivation. Evidence from animal studies and fMRI in humans support the hypothesis that multiple, but similar brain circuits are disrupted in obesity and drug dependence and for the most part, implicate the involvement of DA-modulated reward circuits in pathologic eating behaviors. Based on a consensus of neuroscience research treatment of both glucose and drug like cocaine, opiates should incorporate dopamine agonist therapy in contrast to current theories and practices that utilizes dopamine antagonistic therapy. Considering that up until now clinical utilization of powerful dopamine D2 agonists have failed due to chronic down regulation of D2 receptors newer targets based on novel less powerful D2 agonists that up-regulate D2 receptors seems prudent. We encourage new strategies targeted at improving DA function in the treatment and prevention of obesity a subtype of reward deficiency.

[1]  M. Bakermans-Kranenburg,et al.  Differential susceptibility to rearing environment depending on dopamine-related genes: New evidence and a meta-analysis , 2011, Development and Psychopathology.

[2]  J. Lakoski,et al.  Restricted feeding with scheduled sucrose access results in an upregulation of the rat dopamine transporter. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[3]  A. El-Sohemy,et al.  Dopamine D2 Receptor Genotype (C957T) and Habitual Consumption of Sugars in a Free-Living Population of Men and Women , 2010, Lifestyle Genomics.

[4]  Margaret A. Madigan,et al.  Neurogenetics of Dopaminergic Receptor Supersensitivity in Activation of Brain Reward Circuitry and Relapse: Proposing “Deprivation-Amplification Relapse Therapy” (DART) , 2009, Postgraduate medicine.

[5]  C. S. Paulose,et al.  Striatal dopamine receptors modulate the expression of insulin receptor, IGF-1 and GLUT-3 in diabetic rats: effect of pyridoxine treatment. , 2012, European journal of pharmacology.

[6]  A. Kaminska,et al.  Correlations between polymorphisms in genes coding elements of dopaminergic pathways and body mass index in overweight and obese women. , 2013, Endokrynologia Polska.

[7]  E. Stice,et al.  Elevated Reward Region Responsivity Predicts Future Substance Use Onset But Not Overweight/Obesity Onset , 2013, Biological Psychiatry.

[8]  E. Stice,et al.  Brain reward region responsivity of adolescents with and without parental substance use disorders. , 2014, Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors.

[9]  Semi Helin,et al.  Effects of intravenous glucose on dopaminergic function in the human brain in vivo , 2007, Synapse.

[10]  K. Blum,et al.  "Liking" and "wanting" linked to Reward Deficiency Syndrome (RDS): hypothesizing differential responsivity in brain reward circuitry. , 2012, Current pharmaceutical design.

[11]  Keith F Widaman,et al.  For better and for worse: genes and parenting interact to predict future behavior in romantic relationships. , 2014, Journal of family psychology : JFP : journal of the Division of Family Psychology of the American Psychological Association.

[12]  Z. Demetrovics,et al.  Multivariate Analysis of Dopaminergic Gene Variants as Risk Factors of Heroin Dependence , 2013, PloS one.

[13]  J. Hoenicka,et al.  The A1 allele of the DRD2 gene (TaqI A polymorphisms) is associated with antisocial personality in a sample of alcohol-dependent patients , 2003, European Psychiatry.

[14]  K. Blum,et al.  Low Dopamine Function in Attention Deficit/Hyperactivity Disorder: Should Genotyping Signify Early Diagnosis in Children? , 2014, Postgraduate medicine.

[15]  J. Critchley,et al.  An affected pedigree member analysis of linkage between the dopamine D2 receptor gene TaqI polymorphism and obesity and hypertension. , 2005, International journal of cardiology.

[16]  A. Hajnal,et al.  Accumbens cholinergic interneurons play a role in the regulation of body weight and metabolism , 2000, Physiology & Behavior.

[17]  J. Winkler,et al.  TaqIA polymorphism in dopamine D2 receptor gene complicates weight maintenance in younger obese patients. , 2012, Nutrition.

[18]  V. Routh,et al.  Brain glucosensing and the KATP channel , 2001, Nature Neuroscience.

[19]  R. Young,et al.  D2 dopamine receptor (DRD2) polymorphism is associated with severity of alcohol dependence , 2002, European Psychiatry.

[20]  J. Umhau,et al.  Blood Glucose Is Correlated with Cerebrospinal Fluid Neurotransmitter Metabolites , 2003, Neuroendocrinology.

[21]  L. Epstein,et al.  Multilocus Genetic Composite Reflecting Dopamine Signaling Capacity Predicts Reward Circuitry Responsivity , 2012, The Journal of Neuroscience.

[22]  James Robert Brašić,et al.  Alterations of Central Dopamine Receptors Before and After Gastric Bypass Surgery , 2010, Obesity surgery.

[23]  K. Zavitsanou,et al.  Differential expression of dopamine D2 and D4 receptor and tyrosine hydroxylase mRNA in mice prone, or resistant, to chronic high-fat diet-induced obesity. , 2005, Brain research. Molecular brain research.

[24]  M. Gold,et al.  Neurobiology of food addiction , 2010, Current opinion in clinical nutrition and metabolic care.

[25]  I. Gotlib,et al.  Depressive rumination and the C957T polymorphism of the DRD2 gene , 2012, Cognitive, Affective, & Behavioral Neuroscience.

[26]  O. Yuge,,et al.  The direct effect of dopamine on glucose release from primary cultured rat hepatocytes. , 1998, In vivo.

[27]  Kevin M. Beaver,et al.  The interaction of DRD2 and violent victimization on depression: an analysis by gender and race. , 2009, Journal of affective disorders.

[28]  J. Beuten,et al.  Progress in searching for susceptibility loci and genes for smoking‐related behaviour , 2004, Clinical genetics.

[29]  S. Langenecker,et al.  DRD2 polymorphisms modulate reward and emotion processing, dopamine neurotransmission and openness to experience , 2013, Cortex.

[30]  Y. Hurd,et al.  Cannabis-Dependence Risk Relates to Synergism between Neuroticism and Proenkephalin SNPs Associated with Amygdala Gene Expression: Case-Control Study , 2012, PloS one.

[31]  L. AL-Eitan,et al.  Custom genotyping for substance addiction susceptibility genes in Jordanians of Arab descent , 2012, BMC Research Notes.

[32]  B. Hoebel,et al.  Underweight rats have enhanced dopamine release and blunted acetylcholine response in the nucleus accumbens while bingeing on sucrose , 2008, Neuroscience.

[33]  N. Avena The study of food addiction using animal models of binge eating , 2010, Appetite.

[34]  I. Lee,et al.  Interaction Between Novelty Seeking and the Aldehyde Dehydrogenase 2 Gene in Heroin-Dependent Patients , 2012, Journal of clinical psychopharmacology.

[35]  Simon Gates,et al.  Meta-analysis of the association of the Taq1A polymorphism with the risk of alcohol dependency: a HuGE gene-disease association review. , 2008, American journal of epidemiology.

[36]  A. Somogyi,et al.  Association between the DRD2 A1 allele and response to methadone and buprenorphine maintenance treatments , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[37]  N. Volkow,et al.  Regulation of novelty seeking by midbrain dopamine D2/D3 signaling and ghrelin is altered in obesity , 2014, Obesity.

[38]  E P Noble,et al.  Allelic association of the D2 dopamine receptor gene with cocaine dependence. , 1993, Drug and alcohol dependence.

[39]  Dong D. Wang,et al.  Ethnic Differences in Body Composition and Obesity Related Risk Factors: Study in Chinese and White Males Living in China , 2011, PloS one.

[40]  Allelic association of human dopamine D2 receptor gene in alcoholism. , 1990 .

[41]  Eric Stice,et al.  Neural correlates of food addiction. , 2011, Archives of general psychiatry.

[42]  R. Engels,et al.  Parental control and the dopamine D2 receptor gene (DRD2) interaction on emotional eating in adolescence , 2010, Appetite.

[43]  K. Blum,et al.  Dopamine Genetics and Function in Food and Substance Abuse. , 2013, Journal of genetic syndromes & gene therapy.

[44]  Melissa A. Cyders,et al.  Negative urgency and ventromedial prefrontal cortex responses to alcohol cues: FMRI evidence of emotion-based impulsivity. , 2014, Alcoholism, clinical and experimental research.

[45]  Shengbin Li,et al.  Potential association of DRD2 and DAT1 genetic variation with heroin dependence , 2009, Neuroscience Letters.

[46]  Leonard H Epstein,et al.  Family-based obesity treatment, then and now: twenty-five years of pediatric obesity treatment. , 2007, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[47]  S. Lemeshow,et al.  Dopamine transporter DAT and receptor DRD2 variants affect risk of lethal cocaine abuse: a gene–gene–environment interaction , 2013, Translational psychiatry.

[48]  K. Black,et al.  A comparison of D2 receptor specific binding in obese and normal‐weight individuals using PET with (N‐[11C]methyl)benperidol , 2013, Synapse.

[49]  Wen-sheng Liu,et al.  Association of genetic polymorphisms of glutamate decarboxylase 2 and the dopamine D2 receptor with obesity in Taiwanese subjects , 2012, Annals of Saudi medicine.

[50]  Zhaoping Li,et al.  Association of dopamine D2 receptor and leptin receptor genes with clinically severe obesity , 2013, Obesity.

[51]  B. Gosnell Sucrose intake enhances behavioral sensitization produced by cocaine , 2005, Brain Research.

[52]  C. Adler,et al.  Effects of Acute Metabolic Stress on Striatal Dopamine Release in Healthy Volunteers , 2000, Neuropsychopharmacology.

[53]  Christina L. James,et al.  D1 dopamine agonist and antagonist effects on regional cerebral glucose utilization in rats with intact dopaminergic innervation , 1993, Brain Research.

[54]  Nan-Tsing Chiu,et al.  Correlation between body mass index and striatal dopamine transporter availability in healthy volunteers—A SPECT study , 2008, NeuroImage.

[55]  J. Michael Schurr,et al.  Relation Between Obesity and Blunted Striatal Response to Food Is Moderated by TaqIA A1 Allele , 2008, Science.

[56]  T. Quattrin,et al.  Methylphenidate decreases fat and carbohydrate intake in obese teenagers , 2014, Obesity.

[57]  Marco Pagani,et al.  No association between striatal dopamine transporter binding and body mass index: A multi-center European study in healthy volunteers , 2013, NeuroImage.

[58]  Norio Sugawara,et al.  Association between the dopamine D2 receptor (DRD2) polymorphism and the personality traits of healthy Japanese participants , 2012, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[59]  N. Volkow,et al.  Limbic activation to novel versus familiar food cues predicts food preference and alcohol intake , 2013, Brain Research.

[60]  Serge H. Ahmed,et al.  Cocaine Is Low on the Value Ladder of Rats: Possible Evidence for Resilience to Addiction , 2010, PloS one.

[61]  M. Gold,et al.  The next generation of obesity treatments: beyond suppressing appetite , 2013, Front. Psychol..

[62]  Hanneke E. Creemers,et al.  DRD2 and DRD4 in relation to regular alcohol and cannabis use among adolescents: does parenting modify the impact of genetic vulnerability? The TRAILS study. , 2011, Drug and alcohol dependence.

[63]  Simon Hess,et al.  The fat mass and obesity associated gene (Fto) regulates activity of the dopaminergic midbrain circuitry , 2013, Nature Neuroscience.

[64]  N. Volkow,et al.  Decreased dopamine type 2 receptor availability after bariatric surgery: Preliminary findings , 2010, Brain Research.

[65]  K. Berridge,et al.  The psychology and neurobiology of addiction: an incentive-sensitization view. , 2000, Addiction.

[66]  C. Schwartz,et al.  DRD2 and PPP1R1B (DARPP-32) polymorphisms independently confer increased risk for autism spectrum disorders and additively predict affected status in male-only affected sib-pair families , 2012, Behavioral and Brain Functions.

[67]  D. Oslin,et al.  The Dopamine Receptor D2 (DRD2) SNP rs1076560 is Associated with Opioid Addiction , 2014, Annals of human genetics.

[68]  J. Kennedy,et al.  Dopaminergic system genes in childhood aggression: Possible role for DRD2 , 2012, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[69]  Bo Chen,et al.  The DRD2 rs1800497 polymorphism increase the risk of mood disorder: evidence from an update meta-analysis. , 2014, Journal of affective disorders.

[70]  Kevin M. Beaver,et al.  Gene-Environment Interaction and the Intergenerational Transmission of Parenting: Testing the Differential-Susceptibility Hypothesis , 2012, Psychiatric Quarterly.

[71]  E. Molinari,et al.  D2 dopamine receptor (DRD2) gene Taq1A polymorphism and the eatingrelated psychological traits in eating disorders (anorexia nervosa and bulimia) and obesity , 2007, Eating and weight disorders : EWD.

[72]  Peter A. Groblewski,et al.  Excessive cocaine use results from decreased phasic dopamine signaling in the striatum , 2014, Nature Neuroscience.

[73]  X. Miao,et al.  Association between polymorphisms of DRD2 and DRD4 and opioid dependence: Evidence from the current studies , 2011, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[74]  G. Knudsen,et al.  No correlation between body mass index and striatal dopamine transporter availability in healthy volunteers using SPECT and [123I]PE2I , 2013, Obesity.

[75]  N. Volkow,et al.  Chronic mild stress increases alcohol intake in mice with low dopamine D2 receptor levels. , 2013, Behavioral neuroscience.

[76]  K. Blennow,et al.  Do alcohol-dependent individuals with DRD2 A1 allele have an increased risk of relapse? A pilot study. , 2011, Alcohol and alcoholism.

[77]  Cathi B. Propper,et al.  Bidirectional genetic and environmental influences on mother and child behavior: The family system as the unit of analyses , 2007, Development and Psychopathology.

[78]  Ryan D Ward,et al.  Increasing dopamine D2 receptor expression in the adult nucleus accumbens enhances motivation , 2013, Molecular Psychiatry.

[79]  A. Cincotta,et al.  Bromocriptine/SKF38393 treatment ameliorates obesity and associated metabolic dysfunctions in obese (ob/ob) mice. , 1997, Life sciences.

[80]  Bernard F Fuemmeler,et al.  Genes Implicated in Serotonergic and Dopaminergic Functioning Predict BMI Categories , 2008, Obesity.

[81]  M. Brochu,et al.  The TaqIA RFLP is associated with attenuated intervention-induced body weight loss and increased carbohydrate intake in post-menopausal obese women , 2013, Appetite.

[82]  Thomas J. H. Chen,et al.  LG839: Anti-obesity effects and polymorphic gene correlates of reward deficiency syndrome , 2008, Advances in therapy.

[83]  N. Volkow,et al.  Imaging of Brain Dopamine Pathways: Implications for Understanding Obesity , 2009, Journal of addiction medicine.

[84]  N. Volkow,et al.  Imaging dopamine's role in drug abuse and addiction , 2009, Neuropharmacology.

[85]  K. Blum,et al.  Common Phenotype in Patients with Both Food and Substance Dependence: Case Reports. , 2013, Journal of genetic syndromes & gene therapy.

[86]  E P Noble,et al.  Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. , 1991, Archives of general psychiatry.

[87]  X. Bosch,et al.  Imaging the brain. , 1998, The New England journal of medicine.

[88]  D. Comings,et al.  The D2 Dopamine Receptor Gene as a Determinant of Reward Deficiency Syndrome , 1996, Journal of the Royal Society of Medicine.

[89]  W. Maier,et al.  Association of specific haplotypes of D2 dopamine receptor gene with vulnerability to heroin dependence in 2 distinct populations. , 2004, Archives of general psychiatry.

[90]  J. Wu,et al.  D2 dopamine receptor polymorphism and brain regional glucose metabolism. , 1997, American journal of medical genetics.

[91]  B. Hoebel,et al.  Excessive sugar intake alters binding to dopamine and mu-opioid receptors in the brain , 2001, Neuroreport.

[92]  M. Gold,et al.  Comparing the effects of food restriction and overeating on brain reward systems , 2013, Experimental Gerontology.

[93]  A. Dagher,et al.  Genetic variation in dopaminergic reward in humans. , 2010, Forum of nutrition.

[94]  N. Volkow,et al.  Overexpression of dopamine D2 receptors reduces alcohol self‐administration , 2001, Journal of neurochemistry.

[95]  P. Bieńkowski,et al.  Influence of DRD2 and ANKK1 polymorphisms on the manifestation of withdrawal syndrome symptoms in alcohol addiction , 2012, Pharmacological reports : PR.

[96]  William B. Downs,et al.  Neurogenetics and Clinical Evidence for the Putative Activation of the Brain Reward Circuitry by a Neuroadaptagen: Proposing an Addiction Candidate Gene Panel Map , 2011, Journal of psychoactive drugs.

[97]  R. Young,et al.  Advances in molecular genetics and the prevention and treatment of substance misuse: Implications of association studies of the A1 allele of the D2 dopamine receptor gene. , 2004, Addictive behaviors.

[98]  B. Levin Glucose-regulated dopamine release from substantia nigra neurons , 2000, Brain Research.

[99]  B. Muhlhausler,et al.  Maternal “junk‐food” feeding of rat dams alters food choices and development of the mesolimbic reward pathway in the offspring , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[100]  P. Seeman,et al.  Is schizophrenia a dopamine supersensitivity psychotic reaction? , 2014, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[101]  H. Binns,et al.  Linking Pediatric Primary Care Obesity Management to Community Programs , 2013, Journal of health care for the poor and underserved.

[102]  R. Sansone,et al.  Obesity and substance misuse: is there a relationship? , 2013, Innovations in clinical neuroscience.

[103]  N. Volkow,et al.  Food restriction markedly increases dopamine D2 receptor (D2R) in a rat model of obesity as assessed with in‐vivo μPET imaging ([11C] raclopride) and in‐vitro ([3H] spiperone) autoradiography , 2008, Synapse.

[104]  M. Gold,et al.  Animal Models Lead the Way to Further Understanding Food Addiction as Well as Providing Evidence that Drugs Used Successfully in Addictions Can Be Successful in Treating Overeating , 2013, Biological Psychiatry.

[105]  Y. Hurd,et al.  Dopamine receptor D1 and postsynaptic density gene variants associate with opiate abuse and striatal expression levels , 2013, Molecular Psychiatry.

[106]  G. Collins The next generation. , 2006, Scientific American.

[107]  G. Gervasini,et al.  Influence of Dopamine Polymorphisms on the Risk for Anorexia Nervosa and Associated Psychopathological Features , 2013, Journal of clinical psychopharmacology.

[108]  J. Cheng,et al.  Activation of beta3-adrenoceptors by exogenous dopamine to lower glucose uptake into rat adipocytes. , 1998, Journal of the autonomic nervous system.

[109]  Huiping Zhang,et al.  A large-scale meta-analysis of the association between the ANKK1/DRD2 Taq1A polymorphism and alcohol dependence , 2012, Human Genetics.

[110]  Florence F. Roussotte,et al.  Altered regional brain volumes in elderly carriers of a risk variant for drug abuse in the dopamine D2 receptor gene (DRD2) , 2014, Brain Imaging and Behavior.

[111]  B. Devlin,et al.  Association of Multiple DRD2 Polymorphisms with Anorexia Nervosa , 2005, Neuropsychopharmacology.

[112]  C. Davis,et al.  A Qualitative Study of Binge Eating and Obesity From an Addiction Perspective , 2014, Eating disorders.

[113]  S. Fecteau,et al.  Overlap of food addiction and substance use disorders definitions: Analysis of animal and human studies , 2014, Neuropharmacology.

[114]  K. Saraswathy,et al.  DRD2 and ANKK1 gene polymorphisms and alcohol dependence: a case-control study among a Mendelian population of East Asian ancestry. , 2013, Alcohol and alcoholism.

[115]  J. Michael Schurr,et al.  Relation Between Obesity and Blunted Striatal Response to Food Is Moderated by Taq IA A 1 Allele , 2022 .

[116]  A. S. Freeman,et al.  Effect of glucose on antipsychotic drug-induced changes in dopamine neuronal activity. , 2001, European journal of pharmacology.

[117]  Leonard H. Epstein,et al.  Parent–child concordance of Taq1 A1 allele predicts similarity of parent–child weight loss in behavioral family-based treatment programs , 2010, Appetite.

[118]  J. Shih,et al.  An Extensive Repeat Structure Down‐Regulates Human Monoamine Oxidase A Promoter Activity Independent of an Initiator‐Like Sequence , 1997, Journal of neurochemistry.

[119]  D. Zald,et al.  Changes in dopamine release and dopamine D2/3 receptor levels with the development of mild obesity , 2014, Synapse.

[120]  David K. Grandy,et al.  The Dopamine D2 Receptor , 1992 .

[121]  K. Wittkowski,et al.  Opiate-like effects of sugar on gene expression in reward areas of the rat brain. , 2004, Brain research. Molecular brain research.

[122]  William B. Downs,et al.  Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function of Molecular Neurobiological Mechanisms. , 2012, Journal of addiction research & therapy.

[123]  M. Le Moal,et al.  Critical role of the hypothalamic pituitary adrenal axis in amphetamine-induced sensitization of behavior. , 1990, Life sciences.

[124]  K. Blum,et al.  Reward circuitry dopaminergic activation regulates food and drug craving behavior. , 2011, Current pharmaceutical design.

[125]  C. Marsden,et al.  DR4004, a putative 5-HT(7) receptor antagonist, also has functional activity at the dopamine D2 receptor. , 2002, European journal of pharmacology.

[126]  Shenmin Zhang,et al.  Stress-induced depressive behaviors are correlated with Par-4 and DRD2 expression in rat striatum , 2011, Behavioural Brain Research.

[127]  K. Blum,et al.  Neuro-Genetics of Reward Deficiency Syndrome (RDS) as the Root Cause of "Addiction Transfer": A New Phenomenon Common after Bariatric Surgery. , 2011, Journal of genetic syndromes & gene therapy.

[128]  S. Manuck,et al.  Gene-environment interaction. , 2014, Annual review of psychology.

[129]  J. Hoenicka,et al.  The D2 dopamine receptor gene variant C957T affects human fear conditioning and aversive priming , 2010, Genes, brain, and behavior.

[130]  Y. Zou,et al.  Association of DRD2 gene polymorphisms with mood disorders: a meta-analysis. , 2012, Journal of affective disorders.

[131]  C. Schmidt,et al.  Genetic polymorphisms of DAT1 and COMT differentially associate with actigraphy-derived sleep–wake cycles in young adults , 2014, Chronobiology International.

[132]  M. Jabłoński [Genetic determinants of the alcohol dependence syndrome: searching for an endophenotype associated with sweet liking in families with alcohol addiction]. , 2011, Annales Academiae Medicae Stetinensis.

[133]  Nora D. Volkow,et al.  PET imaging predicts future body weight and cocaine preference , 2012, NeuroImage.

[134]  D. Small,et al.  Relation of reward from food intake and anticipated food intake to obesity: a functional magnetic resonance imaging study. , 2008, Journal of abnormal psychology.

[135]  A. Dagher,et al.  Dopamine-based reward circuitry responsivity, genetics, and overeating. , 2011, Current topics in behavioral neurosciences.

[136]  J. Porter,et al.  Decreased striatal D2 dopamine receptors in obese Zucker rats: changes during aging , 1992, Brain Research.

[137]  T. Garland,et al.  Dopaminergic dysregulation in mice selectively bred for excessive exercise or obesity , 2010, Behavioural Brain Research.

[138]  Eric Stice,et al.  Fasting increases risk for onset of binge eating and bulimic pathology: a 5-year prospective study. , 2008, Journal of abnormal psychology.

[139]  C. Pato,et al.  Review of the putative association of dopamine D2 receptor and alcoholism: a meta-analysis. , 1993, American journal of medical genetics.

[140]  R. Engels,et al.  Initial responses to the first dose of nicotine in novel smokers: The role of exposure to environmental smoking and genetic predisposition , 2014, Psychology & health.

[141]  K. Blum,et al.  Weight Gain Is Associated with Reduced Striatal Response to Palatable Food , 2010, The Journal of Neuroscience.

[142]  R. Wise Dual Roles of Dopamine in Food and Drug Seeking: The Drive-Reward Paradox , 2013, Biological Psychiatry.

[143]  Gabrielle Turner-McGrievy,et al.  D2 dopamine receptor Taq1A polymorphism, body weight, and dietary intake in type 2 diabetes. , 2009, Nutrition.

[144]  K. Blum,et al.  The genetics of problem and pathological gambling: a systematic review. , 2014, Current pharmaceutical design.

[145]  M. Rask-Andersen,et al.  Exposure to a high-fat high-sugar diet causes strong up-regulation of proopiomelanocortin and differentially affects dopamine D1 and D2 receptor gene expression in the brainstem of rats , 2014, Neuroscience Letters.

[146]  N. Volkow,et al.  Striatocortical pathway dysfunction in addiction and obesity: differences and similarities , 2013, Critical reviews in biochemistry and molecular biology.

[147]  N. Volkow,et al.  Obese rats with deficient leptin signaling exhibit heightened sensitivity to olfactory food cues , 2013, Synapse.

[148]  Y. Mitsumoto,et al.  Association between dopamine receptor 2 TaqIA polymorphisms and smoking behavior with an influence of ethnicity: a systematic review and meta-analysis update. , 2013, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[149]  John Mann The Frontiers of Psychology , 1935, Nature.

[150]  K. Brownell Thinking Forward: The Quicksand of Appeasing the Food Industry , 2012, PLoS medicine.

[151]  T. Spector,et al.  Obesity is Associated with Genetic Variants That Alter Dopamine Availability , 2006, Annals of human genetics.

[152]  Nirav R. Shah,et al.  Measuring Adiposity in Patients: The Utility of Body Mass Index (BMI), Percent Body Fat, and Leptin , 2012, PloS one.

[153]  M. Munafo,et al.  Association of the DRD2 gene Taq1A polymorphism and alcoholism: a meta-analysis of case–control studies and evidence of publication bias , 2007, Molecular Psychiatry.

[154]  F. Giubilei,et al.  Intrastriatal injection of D1 or D2 dopamine agonists affects glucose utilization in both the direct and indirect pathways of the rat basal ganglia , 2001, Neuroscience Letters.

[155]  N. Volkow,et al.  Alcohol Reward Is Increased after Roux-en-Y Gastric Bypass in Dietary Obese Rats with Differential Effects following Ghrelin Antagonism , 2012, PloS one.

[156]  Yuying Xie,et al.  The effect of dopamine D2, D5 receptor and transporter (SLC6A3) polymorphisms on the cue‐elicited heroin craving in Chinese , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[157]  J. Reggers,et al.  The TaqI A DRD2 polymorphism in type II alcohol dependence: a marker of age at onset or of a familial disease? , 2009, Alcohol.

[158]  Y. Kato,et al.  Effect of high concentration of glucose on dopamine release from pheochromocytoma-12 cells. , 2003, Metabolism: clinical and experimental.

[159]  J. Hirsch,et al.  Relation between changes in neural responsivity and reductions in desire to eat high-calorie foods following gastric bypass surgery , 2012, Neuroscience.

[160]  K. Blum,et al.  Pharmacotherapies for Overeating and Obesity. , 2013, Journal of genetic syndromes & gene therapy.

[161]  Thomas J. H. Chen,et al.  The Reward Deficiency Syndrome: A Biogenetic Model for the Diagnosis and Treatment of Impulsive, Addictive and Compulsive Behaviors , 2000, Journal of psychoactive drugs.

[162]  Caroline Reid,et al.  Reward sensitivity and the D2 dopamine receptor gene: A case-control study of binge eating disorder , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[163]  Gene-Jack Wang,et al.  Tossing the baby out with the bathwater after a brief rinse? The potential downside of dismissing food addiction based on limited data , 2012, Nature Reviews Neuroscience.

[164]  N. Volkow,et al.  D2R DNA transfer into the nucleus accumbens attenuates cocaine self‐administration in rats , 2008, Synapse.

[165]  Margaret A. Madigan,et al.  Have We Hatched the Addiction Egg: Reward Deficiency Syndrome Solution System™ , 2013, Journal of genetic syndromes & gene therapy.

[166]  Jean Logan,et al.  Brain dopamine and obesity , 2001, The Lancet.